|
|
Articles
Evaluation of two formulations of adjuvanted RTS, S malaria vaccine
in children 3–5 years living in a malaria-endemic region of Mozambique:
a Phase I/IIb randomized double-blind bridging trial
This article was authored by researchers from the Centro de
Investigação
em Saúde de Manhiça (CISM), Manhiça, Mozambique; the
Centro de Salud Internacional, Hospital Clínic/Institut d'Investigacions
Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona,
Barcelona, Spain; Direcção Nacional de Saúde, Ministerio
de Saúde, Maputo, Mozambique; Faculdade de Medicina, Universidade
Eduardo Mondlane, Maputo, Mozambique; Instituto Nacional de Saúde,
Ministerio de Saúde, Maputo, Mozambique; GlaxoSmithKline Biologicals;
and the PATH Malaria Vaccine Initiative.
Click
here for the full article (PDF version) or you can access it online.
A Disease for the Ages
Article by Erica Siguer from the Harvard Health Policy Review.
Africa's economic problems have a medical solution
Dr. Regina Rabinovich on addressing malaria and other infectious diseases
as a critical part of Africa's economic development effort.
Warming to malaria
Arthur Allen, Salon Magazine
With fears mounting that global climate change may cause the dreaded disease
to spread, scientists turn their attention to vaccine research.
|
